StockNews.com downgraded shares of Relx (NYSE:RELX – Free Report) from a buy rating to a hold rating in a report issued on Saturday.
Separately, Redburn Atlantic started coverage on shares of Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock.
View Our Latest Analysis on Relx
Relx Trading Down 2.2 %
Relx Increases Dividend
The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be issued a $0.5586 dividend. The ex-dividend date of this dividend is Friday, May 9th. This is a boost from Relx’s previous semi-annual dividend of $0.23. This represents a yield of 1.6%. Relx’s dividend payout ratio is currently 25.81%.
Institutional Investors Weigh In On Relx
A number of large investors have recently bought and sold shares of RELX. Allspring Global Investments Holdings LLC boosted its holdings in Relx by 3.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 12,874 shares of the technology company’s stock worth $611,000 after purchasing an additional 416 shares in the last quarter. Sequoia Financial Advisors LLC boosted its holdings in Relx by 5.6% in the third quarter. Sequoia Financial Advisors LLC now owns 16,036 shares of the technology company’s stock worth $761,000 after purchasing an additional 844 shares in the last quarter. International Assets Investment Management LLC bought a new stake in Relx in the third quarter worth $1,268,000. Ballentine Partners LLC boosted its holdings in Relx by 1.4% in the third quarter. Ballentine Partners LLC now owns 17,306 shares of the technology company’s stock worth $821,000 after purchasing an additional 240 shares in the last quarter. Finally, Mediolanum International Funds Ltd bought a new stake in Relx in the third quarter worth $12,902,000. 15.02% of the stock is currently owned by institutional investors.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- Want to Profit on the Downtrend? Downtrends, Explained.
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Insider Trading – What You Need to Know
- DuPont’s Electronics Spinoff: The Start of Something Big
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.